TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02986698

In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Cause of deathOther, also futility Automatic label, confidence 0.5, unverified. How labels are made.
“Enrollment ended early due to interim data suggesting a lack of efficacy. Interim data did demonstrate that IUHSCT was safe and well tolerated, but the PI and DSMB agreed that enrollment should not continue under the current treatment protocol.”

The sponsor’s own words in the registry.

Life of this trial

20162017201820192020202120222023202420252026Registered2016-12-05Started2017-10-05Primary completion2024-04-30Stopped2024-12-31

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
University of California, San Francisco
Sponsor type
University, hospital or other
Conditions
Alpha Thalassemia Major; Hemoglobinopathy; With Thalassemia; Hemoglobinopathies; Fetal Anemia; Fetal Hydrops; Alpha; Thalassemia
Interventions
in utero hematopoietic stem cell transplantation
Participants
6
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.